MedTrace Logo

Focal Laser Ablation in Prostate Cancer

NCT06916013 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-04-08

No results posted yet for this study

Summary

To assess the effectiveness of MRI-US or PSMA PET/CT-U/S fusion-guided focal laser ablation (FLA) for the treatment of a localized, intermediate-risk prostate cancer in terms of short-term oncological \& functional outcomes.

Conditions

Interventions

PROCEDURE

Focal laser ablation

Targeted focal laser ablation

PROCEDURE

Focal laser ablation

Targeted focal laser ablation of localized intermediate-risk prostate cancer

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-20
Primary Completion
2027-04-20
Completion
2027-08-20

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06916013 on ClinicalTrials.gov